Cash flow Centene Corporation

Stocks

CNC

US15135B1017

Managed Healthcare

Market Closed - NYSE Other stock markets 06:03:41 16/07/26 am AEST			5-day change	1st Jan Change
66.61 ^USD	-3.07%		-0.72%	+61.87%

15/07	Simpler prior authorizations, digital tools boost trust in insurers, Aetna president says	RE
15/07	Elevance Health shares slide as profit forecast hike not enough to impress investors	RE

d870.wyZCXlXbaPzE-mTUdSxRPPLDhrYN7_8y66a-XcAgjzc.qEkNEG2QEJKxrgrhRUs3aaGt6_VVicoEidP2PqUQwFC6ahEkZoohhrO3NQ

Published financial data: CENTENE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	112B	127B	136B	142B	172B
Total Interest And Dividend Income	422M	520M	1.27B	1.64B	1.57B
Gain (Loss) on Sale of Investments, Total (Rev)	-229M	-	-75M	-	-
Other Revenues, Total	5.66B	8.35B	4.46B	3.2B	3.02B
Total Revenues	118B	136B	141B	147B	176B
Policy Benefits	98.6B	112B	119B	126B	158B
Depreciation & Amortization - (IS) - (Collected)	-	614M	575M	549M	590M
Amortization of Goodwill and Intangible Assets - (IS)	770M	817M	718M	692M	685M
Selling General & Admin Expenses, Total	9.94B	11.37B	12.41B	12.3B	12.88B
Other Operating Expenses	5.18B	7.29B	3.89B	2.97B	3.01B
Total Operating Expenses	114B	132B	136B	142B	175B
Operating Income	3.68B	4.38B	4.81B	4.92B	1.29B
Interest Expense, Total	-665M	-665M	-725M	-702M	-678M
Income (Loss) on Equity Invest.	-	-	-	-	-
EBT, Excl. Unusual Items	3.02B	3.71B	4.09B	4.22B	608M
Restructuring Charges	-54M	-1.64B	-184M	-13M	-24M
Total Merger & Related Restructuring Charges	-157M	-202M	-69M	-82M	-4M
Impairment of Goodwill	-	-	-	-	-6.72B
Gain (Loss) on Sale of Assets	88M	301M	-251M	61M	-511M
Asset Writedown	-	-233M	-	-13M	-75M
Legal Settlements	-1.26B	-6M	-	-	-
Other Unusual Items	184M	30M	15M	83M	1M
EBT, Incl. Unusual Items	1.81B	1.96B	3.6B	4.26B	-6.73B
Income Tax Expense	477M	760M	899M	963M	-51M
Earnings From Continuing Operations	1.34B	1.2B	2.7B	3.29B	-6.68B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.34B	1.2B	2.7B	3.29B	-6.68B
Minority Interest	11M	-	3M	11M	3M
Net Income - (IS)	1.35B	1.2B	2.7B	3.3B	-6.67B
Net Income to Common Incl Extra Items	1.35B	1.2B	2.7B	3.3B	-6.67B
Net Income to Common Excl. Extra Items	1.35B	1.2B	2.7B	3.3B	-6.67B
Per Share Items
Net EPS - Basic	2.31	2.09	4.97	6.33	-13.53
Basic EPS - Continuing Operations	2.31	2.09	4.97	6.33	-13.53
Basic Weighted Average Shares Outstanding	583M	575M	543M	522M	493M
Net EPS - Diluted	2.28	2.07	4.95	6.31	-13.53
Diluted EPS - Continuing Operations	2.28	2.07	4.95	6.31	-13.53
Diluted Weighted Average Shares Outstanding	591M	582M	546M	524M	493M
Normalized Basic EPS	3.25	4.04	4.71	5.08	0.78
Normalized Diluted EPS	3.21	3.99	4.69	5.06	0.78
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	5.16B	5.93B	6.1B	6.16B	2.56B
EBITA	4.45B	5.2B	5.53B	5.62B	1.97B
EBIT	3.68B	4.38B	4.81B	4.92B	1.29B
EBITDAR	5.55B	6.36B	6.45B	6.27B	2.66B
Total Revenues (As Reported)	126B	145B	154B	163B	195B
Effective Tax Rate - (Ratio)	26.31	38.74	24.99	22.62	0.76
Current Domestic Taxes	621M	1.4B	965M	940M	8M
Current Foreign Taxes	7M	4M	1M	-	-
Total Current Taxes	628M	1.41B	966M	940M	8M
Deferred Domestic Taxes	-	-	-	15M	-59M
Deferred Foreign Taxes	-	-	-	8M	-
Total Deferred Taxes	-151M	-649M	-67M	23M	-59M
Normalized Net Income	1.9B	2.32B	2.56B	2.65B	383M
Interest on Long-Term Debt	665M	665M	725M	702M	678M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Net Rental Expense, Total	390M	429M	349M	108M	99M
Imputed Operating Lease Interest Expense	101M	104M	101M	31.67M	28.57M
Imputed Operating Lease Depreciation	289M	325M	248M	76.33M	70.43M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	203M	234M	216M	212M	204M
Total Stock-Based Compensation	203M	234M	216M	212M	204M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	15.58B	17B	18.74B	20.05B	19.47B
Total investments	15.58B	17B	18.74B	20.05B	19.47B
Cash And Equivalents	13.12B	12.07B	17.19B	14.06B	17.89B
Reinsurance Recoverable - (IS)	23M	26M	26M	65M	76M
Other Receivables - (Insurance Template)	12.31B	13.38B	15.66B	19.83B	18.21B
Gross Property Plant And Equipment	8.86B	7.05B	4.82B	5.23B	4.59B
Accumulated Depreciation	-1.9B	-2.07B	-2.4B	-2.8B	-2.23B
Net Property Plant And Equipment	6.96B	4.99B	2.42B	2.43B	2.35B
Goodwill	19.77B	18.81B	17.56B	17.56B	10.84B
Other Intangibles, Total	7.82B	6.91B	6.1B	5.41B	4.53B
Other Current Assets, Total	1.51B	2.33B	5.42B	1.42B	1.76B
Other Long-Term Assets, Total	1.28B	1.35B	1.52B	1.62B	1.62B
Total Assets	78.38B	76.87B	84.64B	82.44B	76.75B
Liabilities
Accounts Payable, Total	8.29B	9.34B	16.25B	13.02B	13.32B
Insurance And Annuity Liabilities	2.33B	1.63B	1.46B	2.01B	1.59B
Unpaid Claims	14.24B	16.74B	18B	18.31B	20.54B
Unearned Premiums	434M	478M	715M	661M	736M
Current Portion of Long-Term Debt	267M	82M	119M	110M	50M
Current Portion of Leases	204M	180M	168M	158M	146M
Long-Term Debt	18.08B	17.68B	17.7B	18.42B	17.35B
Long-Term Leases	4.11B	3.39B	891M	738M	615M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	303M
Deferred Tax Liability Non-Current	1.41B	615M	641M	684M	833M
Other Non Current Liabilities	1.99B	2.48B	2.74B	1.83B	1.2B
Total Liabilities	51.35B	52.63B	58.68B	55.94B	56.69B
Common Stock, Total	1M	1M	1M	1M	1M
Additional Paid In Capital	19.67B	20.06B	20.3B	20.56B	20.78B
Retained Earnings	8.14B	9.34B	12.04B	15.35B	8.67B
Treasury Stock	-1.09B	-4.21B	-5.86B	-9B	-9.44B
Comprehensive Income and Other	77M	-1.13B	-652M	-504M	-58M
Total Common Equity	26.8B	24.06B	25.84B	26.41B	19.95B
Minority Interest	227M	180M	116M	100M	103M
Total Equity	27.02B	24.24B	25.96B	26.51B	20.06B
Total Liabilities And Equity	78.38B	76.87B	84.64B	82.44B	76.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	583M	551M	535M	496M	492M
ECS Total Common Shares Outstanding	582M	551M	534M	496M	492M
Book Value / Share	46	43.68	48.35	53.26	40.57
Tangible Book Value	-800M	-1.67B	2.18B	3.44B	4.59B
Tangible Book Value Per Share	-1.37	-3.02	4.08	6.94	9.33
Total Debt	22.66B	21.33B	18.88B	19.43B	18.16B
Net Debt	9.54B	9.26B	1.68B	5.37B	274M
Debt Equivalent Oper. Leases	3.12B	3.43B	2.79B	864M	792M
Minority Interest, Total (Incl. Fin. Div)	227M	180M	116M	100M	103M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	248M	178M	156M	156M	145M
Buildings, Total	1.12B	659M	534M	523M	492M
Machinery, Total	1.37B	970M	846M	867M	667M
Full Time Employees	72.5K	74.3K	67.7K	60.5K	61.1K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.35B	1.2B	2.7B	3.3B	-6.67B
Depreciation, Depletion & Amortization	706M	736M	575M	549M	590M
Amortization of Goodwill and Intangible Assets - (CF)	770M	817M	718M	692M	685M
Total Depreciation, Depletion & Amortization	1.48B	1.55B	1.29B	1.24B	1.28B
(Gain) Loss On Sale of Asset - (CF)	-88M	-93M	280M	-120M	511M
(Gain) Loss on Sale of Investments - (CF)	229M	-	-	-	-
Total Asset Writedown	-	218M	-	13M	6.8B
Restructuring Activities	-	1.64B	97M	-	-
Stock-Based Compensation (CF)	203M	234M	216M	212M	204M
Change in Accounts Receivable	-2.45B	-1.63B	-2.38B	-4.33B	1.48B
Change in Accounts Payable	1.14B	421M	3.4B	-528M	-657M
Change in Unearned Revenues	-109M	31M	238M	-54M	80M
Change in insurance Reserves / Liabilities	1.8B	2.4B	1.26B	368M	2.34B
Change in Other Net Operating Assets (Collected)	995M	972M	857M	32M	-201M
Other Operating Activities	-338M	-689M	91M	18M	-64M
Cash from Operations	4.2B	6.26B	8.05B	154M	5.09B
Capital Expenditure	-910M	-1B	-799M	-644M	-767M
Cash Acquisitions	-534M	-1.46B	-	-	-
Divestitures	68M	2.48B	707M	990M	-
Investment in Marketable and Equity Securities, Total	-1.94B	-2.93B	-1.1B	-1.4B	1.24B
Other Investing Activities, Total	19M	-	-	-	-
Cash from Investing	-3.3B	-2.92B	-1.19B	-1.05B	472M
Long-Term Debt Issued, Total	9.27B	360M	2.34B	1.3B	750M
Total Debt Issued	9.27B	360M	2.34B	1.3B	750M
Long-Term Debt Repaid, Total	-7.43B	-1.49B	-2.32B	-622M	-1.9B
Total Debt Repaid	-7.43B	-1.49B	-2.32B	-622M	-1.9B
Issuance of Common Stock	-	70M	44M	46M	37M
Repurchase of Common Stock	-297M	-3.1B	-1.63B	-3.12B	-475M
Other Financing Activities, Total	-174M	-41M	-88M	-6M	-38M
Cash from Financing	1.36B	-4.2B	-1.66B	-2.41B	-1.62B
Foreign Exchange Rate Adjustments	-11M	-11M	-32M	8M	-
Miscellaneous Cash Flow Adjustments	-	-16M	-50M	-	-138M
Net Change in Cash	2.26B	-884M	5.12B	-3.3B	3.8B
Supplemental Items
Cash Interest Paid	658M	657M	688M	688M	647M
Cash Income Tax Paid (Refund)	678M	1.22B	883M	1B	448M
Net Debt Issued / Repaid	1.83B	-1.13B	19M	678M	-1.14B
Levered Free Cash Flow	3.88B	3.34B	5.98B	638M	5.05B
Unlevered Free Cash Flow	4.29B	3.75B	6.44B	1.08B	5.48B
Change In Net Working Capital	-1.22B	-233M	-2.72B	2.81B	-3.96B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.13	3.53	3.72	3.68	1.01
Return on Total Capital	4.9	5.75	6.65	6.78	1.91
Return On Equity %	5.04	4.69	10.75	12.56	-28.68
Return on Common Equity	5.12	4.73	10.83	12.65	-28.79
Margin Analysis
Gross Profit Margin %	16.56	17.99	15.85	14.57	10.47
SG&A Margin	8.41	8.36	8.78	8.36	7.31
EBITDA Margin %	4.36	4.36	4.32	4.19	1.45
EBITA Margin %	3.77	3.82	3.91	3.82	1.12
EBIT Margin %	3.11	3.22	3.41	3.35	0.73
Income From Continuing Operations Margin %	1.13	0.88	1.91	2.24	-3.79
Net Income Margin %	1.14	0.88	1.91	2.25	-3.79
Net Avail. For Common Margin %	1.14	0.88	1.91	2.25	-3.79
Normalized Net Income Margin	1.6	1.71	1.81	1.8	0.22
Levered Free Cash Flow Margin	3.28	2.45	4.23	0.43	2.87
Unlevered Free Cash Flow Margin	3.63	2.76	4.55	0.73	3.11
Asset Turnover
Asset Turnover	1.61	1.75	1.75	1.76	2.21
Fixed Assets Turnover	21.4	22.77	38.18	60.79	73.7
Receivables Turnover (Average Receivables)	10.3	10.03	9.52	8.19	9.19
Short Term Liquidity
Current Ratio	1.11	1.06	1.11	1.11	1.1
Quick Ratio	1.04	0.97	0.96	1.06	1.05
Operating Cash Flow to Current Liabilities	0.16	0.22	0.22	0	0.14
Days Sales Outstanding (Average Receivables)	35.43	36.4	38.33	44.66	39.72
Average Days Payable Outstanding	84.44	86.05	97.38	100.5	79.61
Long Term Solvency
Total Debt/Equity	83.86	88.02	72.73	73.29	90.56
Total Debt / Total Capital	45.61	46.81	42.11	42.29	47.52
LT Debt/Equity	82.12	86.94	71.62	72.28	89.58
Long-Term Debt / Total Capital	44.66	46.24	41.46	41.71	47.01
Total Liabilities / Total Assets	65.52	68.47	69.33	67.85	73.87
EBIT / Interest Expense	5.54	6.58	6.64	7.01	1.9
EBITDA / Interest Expense	8.34	9.57	8.9	8.93	3.92
(EBITDA - Capex) / Interest Expense	6.97	8.06	7.8	8.02	2.79
Total Debt / EBITDA	4.09	3.35	2.92	3.1	6.83
Net Debt / EBITDA	1.72	1.46	0.26	0.86	0.1
Total Debt / (EBITDA - Capex)	4.89	3.98	3.34	3.45	9.59
Net Debt / (EBITDA - Capex)	2.06	1.73	0.3	0.95	0.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.44	15.14	3.89	4.07	19.71
Gross Profit, 1 Yr. Growth %	9.28	25.41	-8.47	-4.72	-13.94
EBITDA, 1 Yr. Growth %	-3.95	16.43	5.1	-0.68	-58.45
EBITA, 1 Yr. Growth %	-7.83	18.39	6.43	-0.28	-64.9
EBIT, 1 Yr. Growth %	-10.44	21	9.89	0.2	-73.88
Earnings From Cont. Operations, 1 Yr. Growth %	-25.53	-10.03	124.54	22.05	-302.7
Net Income, 1 Yr. Growth %	-25.5	-10.76	124.79	22.32	-301.94
Normalized Net Income, 1 Yr. Growth %	-10.89	24.98	10.17	1.09	-85.54
Diluted EPS Before Extra, 1 Yr. Growth %	-26.92	-9.21	139.13	27.47	-314.49
Net Property, Plant and Equip., 1 Yr. Growth %	70.31	-28.33	-51.56	0.46	-2.97
Accounts Receivable, 1 Yr. Growth %	26.28	8.44	17.04	26.9	-8.24
Total Assets, 1 Yr. Growth %	14.05	-1.92	10.11	-2.59	-6.91
Common Equity, 1 Yr. Growth %	3.97	-10.22	7.41	2.21	-24.45
Tangible Book Value, 1 Yr. Growth %	-36.86	108.25	-230.91	57.86	33.26
Cash From Operations, 1 Yr. Growth %	-23.59	48.89	28.62	-98.09	3.2K
Capital Expenditures, 1 Yr. Growth %	4.72	10.33	-20.42	-19.4	19.1
Levered Free Cash Flow, 1 Yr. Growth %	-44.54	-13.08	86.12	-89.44	691.85
Unlevered Free Cash Flow, 1 Yr. Growth %	-42.35	-11.8	77.29	-83.43	408.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.19	14.2	9.16	4.02	11.62
Gross Profit, 2 Yr. CAGR %	28.01	16.54	5.9	-6.4	-9.45
EBITDA, 2 Yr. CAGR %	26.49	4.11	6.2	3.01	-35.76
EBITA, 2 Yr. CAGR %	25.23	2.63	6.8	3.95	-40.84
EBIT, 2 Yr. CAGR %	19.45	1.94	8.63	6.03	-48.84
Earnings From Cont. Operations, 2 Yr. CAGR %	1.03	-18.15	42.13	65.54	57.29
Net Income, 2 Yr. CAGR %	0.98	-18.46	41.63	65.82	57.16
Normalized Net Income, 2 Yr. CAGR %	17.77	2.89	9.21	6.83	-61.77
Diluted EPS Before Extra, 2 Yr. CAGR %	-14.79	-18.55	47.34	74.59	65.35
Net Property, Plant and Equip., 2 Yr. CAGR %	58.14	10.48	-41.08	-30.25	-1.27
Accounts Receivable, 2 Yr. CAGR %	40.06	17.02	12.67	21.78	7.91
Total Assets, 2 Yr. CAGR %	38.27	5.76	3.92	3.56	-4.78
Common Equity, 2 Yr. CAGR %	46.11	-3.39	-1.8	4.78	-12.13
Tangible Book Value, 2 Yr. CAGR %	-53.02	14.67	65.11	43.76	45.04
Cash From Operations, 2 Yr. CAGR %	68.39	6.66	38.39	-84.32	-20.51
Capital Expenditures, 2 Yr. CAGR %	11.65	7.49	-6.3	-19.91	-2.02
Levered Free Cash Flow, 2 Yr. CAGR %	144.07	-31.24	22.52	-55.44	-8.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	117.4	-29.32	20.93	-45.53	-8.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	27.75	24.3	10.66	7.46	9.01
Gross Profit, 3 Yr. CAGR %	22.57	27	7.53	2.39	-8.98
EBITDA, 3 Yr. CAGR %	25.21	22.55	3.71	4.43	-23.89
EBITA, 3 Yr. CAGR %	23.85	22.34	3.88	5.02	-27.61
EBIT, 3 Yr. CAGR %	19.97	19.28	4.52	6.48	-33.53
Earnings From Cont. Operations, 3 Yr. CAGR %	14.33	-2.8	14.58	35.09	77.1
Net Income, 3 Yr. CAGR %	14.39	-3.1	14.33	34.88	77.08
Normalized Net Income, 3 Yr. CAGR %	19.04	19.3	5.26	7.3	-45.15
Diluted EPS Before Extra, 3 Yr. CAGR %	0.29	-12.97	16.63	40.4	86.99
Net Property, Plant and Equip., 3 Yr. CAGR %	59.76	21.47	-16.07	-29.61	-22.13
Accounts Receivable, 3 Yr. CAGR %	33.59	28.61	17.03	17.17	10.81
Total Assets, 3 Yr. CAGR %	36.38	23.31	7.19	1.7	-0.05
Common Equity, 3 Yr. CAGR %	34.89	24.22	0.09	-0.48	-6.04
Tangible Book Value, 3 Yr. CAGR %	-21.65	-22.83	19.85	62.66	40.17
Cash From Operations, 3 Yr. CAGR %	50.48	61.62	13.53	-66.79	-6.68
Capital Expenditures, 3 Yr. CAGR %	10.47	11.21	-2.76	-10.89	-8.58
Levered Free Cash Flow, 3 Yr. CAGR %	32.61	72.43	-5.36	-45.7	16.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.75	60.45	-5.03	-37.45	14.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	25.68	24.31	20.04	15.75	11.05
Gross Profit, 5 Yr. CAGR %	22.63	25.19	16.07	12.41	0.48
EBITDA, 5 Yr. CAGR %	22.25	26.57	18.37	13.85	-14.09
EBITA, 5 Yr. CAGR %	20.42	26.23	18.74	14.62	-16.76
EBIT, 5 Yr. CAGR %	17.97	24.48	17.68	13.79	-21.13
Earnings From Cont. Operations, 5 Yr. CAGR %	18.95	8.27	24.73	20.27	30.06
Net Income, 5 Yr. CAGR %	19.1	7.74	24.59	20.13	29.85
Normalized Net Income, 5 Yr. CAGR %	16.8	24.49	17.87	14.15	-29.46
Diluted EPS Before Extra, 5 Yr. CAGR %	5.92	-2.42	16.98	14.98	34.11
Net Property, Plant and Equip., 5 Yr. CAGR %	54.24	35.19	7.2	-2.7	-10.44
Accounts Receivable, 5 Yr. CAGR %	30.64	31.3	24.79	25.84	13.26
Total Assets, 5 Yr. CAGR %	31.15	28.6	22.33	15	2.23
Common Equity, 5 Yr. CAGR %	35.37	28.56	18.81	16.04	-4.99
Tangible Book Value, 5 Yr. CAGR %	17.19	18.83	5.57	-1.02	29.35
Cash From Operations, 5 Yr. CAGR %	17.83	33.28	45.52	-36.43	-1.56
Capital Expenditures, 5 Yr. CAGR %	24.36	18.93	3.43	-2.48	-2.47
Levered Free Cash Flow, 5 Yr. CAGR %	2.69	19.96	29.18	-0.4	-6.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.98	20.09	27.94	3.46	-6.13